This HTML5 document contains 95 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63381136
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu n'abril de 2015 wetenschappelijk artikel scientific article published on 04 April 2015 im April 2015 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована у квітні 2015 article scientifique publié en 2015
p:P577
wds:Q63381136-CB1D9DA3-0050-4042-9281-09A7C0AD56A7
wdt:P577
2015-04-04T00:00:00Z
p:P2860
wds:Q63381136-F2527779-FEFB-49B0-A6C8-E314A336E7D4 wds:Q63381136-F9A46921-6E16-4E5E-B82C-DC08E683EA51 wds:Q63381136-E33D391B-B0AC-40E8-97F1-9D060D7F8F5B wds:Q63381136-EEE4D8F7-90EF-4699-9EDF-B0EE37B559A3 wds:Q63381136-6154BFF2-B0A6-4F3C-A579-CB10281A9A75 wds:Q63381136-67C3EF7E-BF19-4C68-9698-428EFA26B47B wds:Q63381136-5A2D4D02-A659-4506-97B1-02AD9E646743 wds:Q63381136-611522CD-F207-4E3C-9F7D-60C9062FFE2E wds:Q63381136-28CE38A4-B80F-452F-8A04-74A33235146C wds:Q63381136-2E5B4A17-B372-42E9-92E9-83D303350A2C wds:Q63381136-2FE6A732-BB90-4461-94FF-35F582259053 wds:Q63381136-127CEC5E-E148-4D8C-BE47-7440EE8AF22A wds:Q63381136-18CCAB07-298F-4E31-82A4-0C71670BB0B6 wds:Q63381136-1EE67A30-7EEE-4618-B686-0A67F3711803 wds:Q63381136-CC3BA8EF-C230-460F-A4DB-6305287B4506 wds:Q63381136-D38EF893-0508-4409-905E-9C524F3FF695 wds:Q63381136-DC6BA952-4025-45DE-BDE4-9295EBB01354 wds:Q63381136-9BAE39AE-EC52-4B5B-B95E-425778E4D7D8 wds:Q63381136-AB54B158-52C9-48A7-A275-1F9AD3AA5D7A wds:Q63381136-AD1EE1F0-AB87-455E-A890-08653E2C2835 wds:Q63381136-856BE9CC-9499-4530-A50F-023F7277F806 wds:Q63381136-8D6B4C37-484D-41E0-933C-A978DCE2CF40 wds:Q63381136-00B5F516-D9DD-4B5B-940A-9BA88B2EA5A5 wds:Q63381136-02729F44-7000-4732-A91F-9230269CE570
wdt:P2860
wd:Q42557625 wd:Q33495006 wd:Q38248872 wd:Q45264756 wd:Q79397162 wd:Q33314463 wd:Q58971291 wd:Q30837900 wd:Q72848077 wd:Q83654089 wd:Q63381151 wd:Q34523564 wd:Q37381636 wd:Q31445286 wd:Q50956690 wd:Q47755620 wd:Q85918678 wd:Q81067569 wd:Q86684382 wd:Q39956216 wd:Q35622614 wd:Q73236191 wd:Q39492808 wd:Q46011695
p:P2093
wds:Q63381136-BF1EF9B8-D0A7-4047-96BE-CA36C7615471 wds:Q63381136-D7DCA0AF-4A91-4408-A092-3CF269A4F283 wds:Q63381136-03B75156-0B23-46DC-8AB5-B6D2DD7E0166
wdt:P2093
Sarika Gupta Abul Kalam Kapil Manglani
rdfs:label
Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation
skos:prefLabel
Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation
schema:name
Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation
p:P50
wds:Q63381136-7B87C981-0C36-455F-B180-9E3585F2CB5D wds:Q63381136-4716C85D-D178-4520-A713-F74A08375846 wds:Q63381136-49C21DC8-4CB7-46BC-969F-24EEC3D4A05E wds:Q63381136-5751D009-B3C6-49F5-B5CE-C9618E0E1FE9
wdt:P50
wd:Q86560339 wd:Q42182005 wd:Q43145694 wd:Q87052413
p:P1476
wds:Q63381136-6D5C50DB-DAD4-4375-BF57-FD6B1A5569FF
wdt:P1476
Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation
p:P304
wds:Q63381136-94D095D7-AB66-4A04-9DD8-71AEDFCE0189
wdt:P304
3149-3158
p:P31
wds:Q63381136-BA3261A8-1FEF-45EB-AF0E-CB78FA659D05
wdt:P31
wd:Q13442814
p:P698
wds:Q63381136-E2638E16-436D-49BD-9BE1-5A43602B206A
wdtn:P698
n10:25840949
wdt:P698
25840949
p:P1433
wds:Q63381136-CBA17DB4-FAE9-44FC-86E3-0B7FA8DE753B
wdt:P1433
wd:Q7180737
p:P433
wds:Q63381136-E4C016C3-4348-415D-8985-70240D1130D1
p:P478
wds:Q63381136-84972B86-275D-4E4F-BFFE-B27B4E0FF45D
wdt:P433
10
wdt:P478
32
p:P356
wds:Q63381136-7634BCDD-9B95-4821-AC97-FAF0FA0751D5
wdtn:P356
n12:S11095-015-1692-4
wdt:P356
10.1007/S11095-015-1692-4